PRV111 Patch Topical cancer treatment developed by Privo Technologies PEABODY, Mass. - June 3, 2021 - (Newswire.com) Privo Technologies, Inc. ("Privo"), a biopharmaceutical company focused on optimizing state-of-the-art chemotherapies to be "Tough on cancer, Easy on patients", ann...